Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 14, 2021

SELL
$33.06 - $56.93 $351,593 - $605,450
-10,635 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$39.09 - $57.4 $415,722 - $610,449
10,635 New
10,635 $445,000
Q3 2020

Nov 13, 2020

SELL
$28.43 - $44.67 $291,748 - $458,403
-10,262 Closed
0 $0
Q2 2020

Aug 17, 2020

BUY
$11.71 - $30.29 $120,168 - $310,835
10,262 New
10,262 $311,000

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Parametrica Management LTD Portfolio

Follow Parametrica Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parametrica Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Parametrica Management LTD with notifications on news.